IGF1 and breast cancer: This observation strengthens the hypothesis that it is the combination of the IGF1-19/-19 genotype and multiparity that is deleterious and suggests that the IGF1-19/-19 genotype may be associated with a substantial number of the early-onset breast cancers in the developing world where both this genotype and multiparity are common.